Intabio has developing analytical solutions to transform biotherapeutic development. Founded by Erik Gentalen and Lena Wu in 2015, Intabio is backed by investors that include Northpond Ventures, Vertical Venture Partners, Genoa Ventures, and National Center for Advancing Translational Sciences(NCATS) and is headquartered in Sunnyvale.